Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.
Werner RA, Lapa C, Ilhan H, Higuchi T, Buck AK, Lehner S, Bartenstein P, Bengel F, Schatka I, Muegge DO, Papp L, Zsótér N, Große-Ophoff T, Essler M, Bundschuh RA.
Werner RA, et al. Among authors: bundschuh ra.
Oncotarget. 2017 Jan 24;8(4):7039-7049. doi: 10.18632/oncotarget.12402.
Oncotarget. 2017.
PMID: 27705948
Free PMC article.
Clinical Trial.